Contraindicated. Coadministration of doravirine with a solid CYP3A inducer could lower doravirine plasma concentrations and/or effects. Possible for lack of virologic response and doable resistance to doravirine. pentobarbital will reduce the level or outcome of dapsone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unidentified. With therapeutic do... https://wilhelmq185put7.gynoblog.com/profile